These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10158078)

  • 1. I.V. solution prices are holding steady; little price change, up or down, expected.
    Hosp Mater Manage; 1996 Jun; 21(6):1, 10-1. PubMed ID: 10158078
    [No Abstract]   [Full Text] [Related]  

  • 2. I.V. solution prices to jump 7%.
    Barlow RD
    Hosp Mater Manage; 1991 Oct; 16(10):1, 12-3. PubMed ID: 10115097
    [No Abstract]   [Full Text] [Related]  

  • 3. IV solution prices continue their slide.
    Hosp Mater Manage; 1995 Jul; 20(7):1, 12-3. PubMed ID: 10143907
    [No Abstract]   [Full Text] [Related]  

  • 4. Price survey. I.V. prices expected to stabilize.
    Hosp Mater Manage; 2001 May; 26(5):1, 12-4. PubMed ID: 11357261
    [No Abstract]   [Full Text] [Related]  

  • 5. Price survey. Overall, i.v. solution prices edging up.
    Hosp Mater Manage; 1996 Nov; 21(11):1, 10-1. PubMed ID: 10162842
    [No Abstract]   [Full Text] [Related]  

  • 6. Price survey. Most i.v. prices will hold steady.
    Hosp Mater Manage; 2003 Sep; 28(9):1, 11-3. PubMed ID: 12971040
    [No Abstract]   [Full Text] [Related]  

  • 7. Price survey. I.v. prices appear headed upward.
    Hosp Mater Manage; 2002 Jul; 27(7):1, 12-3. PubMed ID: 12134381
    [No Abstract]   [Full Text] [Related]  

  • 8. I.v. solutions prices steady, but increases may come soon.
    Brightbill T
    Hosp Mater Manage; 1988 Apr; 13(4):6-8. PubMed ID: 10287172
    [No Abstract]   [Full Text] [Related]  

  • 9. I.V. solution prices remain stable.
    Hosp Mater Manage; 1994 Oct; 19(10):1, 12-3. PubMed ID: 10137917
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic i.v. solutions show price decline.
    Hosp Mater Manage; 1998 Jan; 23(1):1, 15-6. PubMed ID: 10176479
    [No Abstract]   [Full Text] [Related]  

  • 11. Price survey. I.V. prices creep upward again.
    Hosp Mater Manage; 2000 Apr; 25(4):1, 13-5. PubMed ID: 11066731
    [No Abstract]   [Full Text] [Related]  

  • 12. I.v. solution prices stabilize.
    Hosp Mater Manage; 1993 Oct; 18(10):1, 13-4. PubMed ID: 10129786
    [No Abstract]   [Full Text] [Related]  

  • 13. Resource markets nudge IV prices up, survey says.
    Hosp Mater Manage; 2005 Nov; 30(11):1, 11-13. PubMed ID: 16363490
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
    Gross DJ; Schondelmeyer SW; Raetzman SO
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prices on i.v. administration sets unstable.
    Brightbill TC
    Hosp Mater Manage; 1987 May; 12(5):3-5. PubMed ID: 10282706
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic drug prices said headed up.
    Hosp Mater Manage; 1998 May; 23(5):1, 15. PubMed ID: 10179472
    [No Abstract]   [Full Text] [Related]  

  • 17. What is the real price of cost containment?
    Morris SN
    J Intraven Nurs; 1989; 12(1 Suppl):S19-22. PubMed ID: 2913263
    [No Abstract]   [Full Text] [Related]  

  • 18. IV solution prices going up 6% to 7%.
    Litsikas M
    Hosp Mater Manage; 1989 Nov; 14(11):1, 8-9. PubMed ID: 10324703
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug prices edging upward again.
    Hosp Mater Manage; 1999 May; 24(5):1, 12-3. PubMed ID: 10387816
    [No Abstract]   [Full Text] [Related]  

  • 20. Generic drug prices continue to slide.
    Hosp Mater Manage; 1997 May; 22(5):1, 10. PubMed ID: 10167084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.